active

Epix AI

LEARN MORE
Status
active
Days Left
40 days left
Minimum Investment
$150,000
Funding Goal
$2,000,000
Raised so far
$0
Business Type
Limited liability company (LLC)
Registered in
URL

THE COMPANY

Vision and Mission

Our mission is to prevent the development of age-related diseases, which are responsible for roughly 70% of all deaths. These are preventable diseases that are linked to our lifestyle and deteriorating nutrition, sleep, and physical activity.

Why Do We Exist

We believe that the combination of epigenetics and AI is the most effective way to tackle the issue of age-related diseases. Our company combines these two approaches to fighting preventable diseases and extending people's health span.

The Problem

We all carry genes that make us predisposed to age-related diseases. However, these can remain dormant for the rest of our lives, or they could become active and cause the development of these diseases. We track how gene activity changes over time and we help people manage and reduce their risk.

Who Has This Problem

Every human being on the planet carries the risk of age-related diseases in their genes.

Our Solution

We offer epigenetic tests and we use AI to analyze the results and help people minimize their risks.

How It Works

We take a blood sample from you, ship it off for sequencing, and analyze the results to find the top 3 most clinically significant genetic predispositions in cardiovascular, metabolic and neurodegenerative diseases and activation of predisposition to type 2 diabetes. In addition, we also establish the client's biological age, which shows us the overall condition of their cells and tissues. An advanced biological age shows a greater risk of age-related diseases and would require closer attention.

Why Invest in Us

We have the most advanced way of measuring the risk of age-related diseases. Additionally, the company can produce genetically personalized supplements, aimed at minimizing your risks. We are also working on an app to keep track of medication taken by the client and to match their genetic predispositions to the ingredients in the medication - giving an accurate analysis of the medication's effectiveness, but also side effects.

THE BUSINESS

Business Model

We have a collaboration with a preventive clinic in Sofia, so we are targeting B2B2C. The clinic offers our tests as a part of a larger longevity package, that also includes examinations with specialists and experts. 

Value Proposition

“Personalized health optimization through secure, cutting-edge epigenetic testing—helping you stay healthier, avoid unnecessary doctor visits, and make smarter choices about supplements and medications, all while ensuring your data remains private and protected.


Key Differentiators:

Fewer sick days, more vitality – Actionable insights to strengthen your health.
Truly personalized supplements – Designed only for you, not available in pharmacies.
Smarter medication choices – Pharmacogenetic analysis helps avoid bad reactions.
Unmatched data privacy – Blockchain-secured in Switzerland, delivered on a USB stick.
Access to expert care – Partner clinics in Austria for advanced preventive treatment.

The core promise: A healthier, more informed, and more empowered you—backed by science and privacy-first technology.


Sales Channels

We are now selling through our partnering clinic, but we are also considering partnerships and sales through partnering voluntary insurance funds, corporate wellness programs, as well as sales through our mobile application.

Products

With a simple, at-home sample collection, we analyze not only your DNA but also how your lifestyle and environment influence your genes. This goes beyond standard genetic testing; we focus on epigenetics, the key to understanding how you can actively shape your health.

What makes us different? First, you’ll receive customized supplements that are made specifically for you—formulated based on your unique genetic and epigenetic profile. These aren’t generic vitamins you can buy in a store; they are crafted to support your body’s exact needs.

Second, we provide pharmacogenetic insights, showing how your body reacts to different medications. This means you can make informed decisions about the drugs you take, avoiding negative side effects and ensuring the most effective treatment options.

When it comes to your data, we take privacy seriously. Unlike many companies that store sensitive information in the cloud, we secure everything on Swiss blockchain technology. Your results are delivered to you on a USB stick, so you—and only you—control your data.

For those who want to go even further, our partner clinic in Austria offers advanced preventive care. You can consult with specialists, get in-depth health evaluations, and create a long-term wellness plan that works with your unique biology.

This isn’t just a test—it’s a game changer for your health, helping you prevent illness, optimize your well-being, and make the most informed choices for your future.

Production

We take great care in the production of our epigenetic testing and personalized supplement solutions. Our process begins with state-of-the-art genetic and epigenetic analysis, using the latest scientific advancements to decode how your body responds to lifestyle, nutrition, and medication.

Once your data is analyzed, we create custom-formulated supplements designed specifically for you. Unlike mass-produced vitamins, our formulations are precision-crafted based on your unique genetic profile, ensuring that you get exactly what your body needs—nothing more, nothing less.

Every step of our production follows strict quality and safety standards, using pharmaceutical-grade ingredients and advanced compounding techniques. We work with top-tier laboratories and manufacturers to guarantee purity, effectiveness, and 100% personalized results.

Patents

We do not have any patensts so far.

Competition

Most genetic testing companies offer generic reports with limited practical use. They tell you about your ancestry or genetic traits, but they don’t provide actionable solutions. Others might offer health insights, but they don’t go beyond static DNA data—they ignore epigenetics, which shows how your lifestyle influences your genes in real-time.

Some companies sell supplements based on genetic testing, but these are often pre-made formulas with minor adjustments, not truly personalized solutions. And when it comes to data privacy, many store sensitive health information in the cloud, where it’s vulnerable to breaches and third-party access.

We do things differently. We analyze not just your DNA, but also how your environment and habits shape your health, offering a fully personalized supplement regimen designed exclusively for you. Plus, we ensure complete privacy—your data is stored securely on a Swiss blockchain and delivered directly to you, giving you full control.

With us, you don’t just get insights—you get a real plan for better health, backed by science and built for you alone.

Market Potential

The market for personalized health and epigenetic testing is growing rapidly, driven by increasing demand for preventive healthcare, personalized medicine, and data security.

We are launching in Europe, where awareness of preventive health is high, and regulations favor innovative wellness solutions. With partnerships in Austria and expansion into corporate wellness programs and voluntary health insurance funds, we are tapping into a market eager for science-backed, data-secure health optimization.

As we establish our presence in Europe, the next step is the United States, where interest in personalized supplements, pharmacogenetics, and biohacking is booming. The U.S. market offers enormous potential, with a strong demand for direct-to-consumer genetic testing and corporate health programs. Our unique approach—combining epigenetics, truly personalized supplements, and blockchain-secured data—positions us ahead of existing competitors.

With growing awareness, regulatory support, and increasing consumer demand for personalized healthcare, we are set to become a leading name in the global health optimization market. We estimate our SOM in Europe at 2,9 billion Euros

THE MARKET SOLUTION

Market Opportunity

The global market for personalized health and epigenetic testing is expanding at an unprecedented rate. People are moving away from one-size-fits-all healthcare and demanding personalized solutions that help them stay healthier, prevent illness, and optimize their well-being.

In Europe, the demand for preventive healthcare, corporate wellness programs, and advanced health diagnostics is increasing. Governments and insurers are recognizing the long-term benefits of proactive health management, creating a perfect entry point for our service.

In the United States, the market for genetic testing, biohacking, and personalized supplements is already thriving, with consumers eager to invest in science-backed health solutions. However, existing services often lack epigenetic insights, true supplement personalization, and strong data privacy protections—key advantages that set us apart.

With growing health awareness, advancements in genomics, and a shift toward preventive and personalized medicine, we are entering a multi-billion-dollar market at exactly the right time. Our unique approach positions us as a leader in the next generation of data-secure, science-driven, and truly personalized health optimization.

Go to Market Plans

We are launching with a strategic, multi-phase approach that ensures strong market entry, rapid customer acquisition, and scalable growth.

Phase 1: Establishing in Europe (Year 1-2)

  1. Leverage Our Partner Clinic in AustriaIntegrate our test into their preventive care programs.Train doctors to recommend our service to patients.Offer premium health packages combining our test with clinic services.
  2. Collaborate with Voluntary Health Insurance FundsPartner with private health insurers to include our test in wellness programs.Provide insurers with data-driven proof that personalized health reduces claims.Offer flexible pricing models where insurers cover full/partial test costs.
  3. Target Corporate Wellness ProgramsPitch to HR departments of companies focused on employee health & productivity.Offer on-site health screenings and workshops.Create subscription models for ongoing supplement delivery.
  4. Direct-to-Consumer (DTC) Online SalesLaunch a content-driven marketing strategy (blog, webinars, case studies).Run targeted digital ads to health-conscious consumers.Establish credibility through influencers, biohackers, and health professionals.

Phase 2: Expansion into the U.S. (Year 2-4)

  1. Secure Regulatory Compliance & Strategic PartnershipsAdapt to FDA & HIPAA regulations.Partner with functional medicine doctors, longevity clinics, and wellness centers.
  2. Expand Corporate & Insurance PartnershipsApproach U.S. health insurers with proof of concept from Europe.Scale our corporate wellness offerings with large multinational employers.
  3. Scale Direct-to-Consumer SalesEstablish a U.S.-based fulfillment center for faster service.Build a community of early adopters, including tech professionals and biohackers.
  4. Develop Subscription & Retention ModelsOffer ongoing supplement subscriptions based on updated epigenetic testing.Introduce premium membership plans with exclusive health coaching.

Phase 3: Global Growth & Market Leadership (Year 4+)

Regulations

We take regulatory compliance seriously to ensure our service meets the highest standards in every market we enter.

In Europe, we align with GDPR regulations to guarantee strict data privacy and give clients full control over their personal health information. Our use of Swiss blockchain technology ensures that data remains secure, transparent, and accessible only to the client. We also comply with EU medical device and diagnostic regulations to ensure our testing meets scientific and ethical guidelines.

As we expand into the U.S., we are preparing for FDA oversight and ensuring our service complies with HIPAA regulations for health data security. We are also working closely with functional medicine practitioners and healthcare providers to integrate our offering in a compliant and seamless way.

By staying ahead of regulatory requirements, we not only protect our clients' data and trust but also position ourselves as a leader in responsible, science-backed personalized health solutions.

Competition

When I look at our competition, I see companies offering genetic testing, but not like we do. Many provide data, but leave you to figure out what it all means. Others might offer supplements, but they’re generic—not tailored to your unique genetic makeup. And while some focus on security, few go as far as we do, storing your data on a blockchain in Switzerland to ensure it’s truly safe and private.

What sets us apart is how we bring it all together: actionable insights, personalized supplements you can’t get anywhere else, pharmacogenetics to guide your medication choices, and access to top-tier preventive care. We don’t just give you information—we give you a roadmap to better health, designed specifically for you.

Our competition may offer pieces of the puzzle, but we provide the complete picture. We’re not just another testing service; we’re your partner in living a healthier, more vibrant life.

THE TEAM

We have a team of molecular biologists, bioinformaticians, and AI experts who are perfectly positioned to take on the challenge.

THE RISKS

Generic Risk Statement


Our biggest threats to survivability include:

  1. Regulatory Changes: Shifts in healthcare or data privacy laws could increase compliance costs or restrict our operations.
  2. Data Security Breaches: Despite advanced blockchain storage, a breach could damage trust and lead to legal or financial consequences.
  3. Market Competition: Rapidly evolving competitors with similar or lower-cost offerings could erode our market share.
  4. Scientific Advancements: New discoveries in epigenetics or health tech could make our services obsolete if we fail to innovate.
  5. Customer Trust: Misuse or misinterpretation of genetic data by clients could lead to reputational harm or legal issues.
  6. Economic Downturns: Reduced consumer spending during economic crises could impact demand for premium health services.



Technology Risks

It is possible that another company will come up with a better way to analyze data or provide better recommendations. However, we are committed to continued R&D development and insist on implementing the latest developments in our field.

Operational Risks

Operational risks are not that high. The processes in our field are highly commodified and do not pose a significant risk

Macroeconomic Risks

Economic downturn may very well suppress consumer confidence and inhibit spending on prevention. However, our emphasis on the impact lifestyle has on health will be underlined during economic downturn. 

People Risks

We are a small team of committed professionals. The team dynamic is very egalitarian and horizontal so we have good communication and a lot of flexibility. There are no immediate risks ahead of us.

Market Risks

Market risks include intense competition, rapid technological advancements, and shifting consumer preferences. Economic downturns may reduce demand for premium services, while regulatory changes could increase costs. Failure to differentiate or adapt could erode market share. Staying innovative, customer-focused, and compliant is essential to navigate these challenges and maintain growth.

Regulatory Risks

Regulatory risks include changes in healthcare, data privacy, or genetic testing laws that could increase compliance costs or restrict operations. Non-compliance could lead to fines, legal action, or reputational damage. Through our legal partners we stay on top of these fields, to ensure that we are compliant with all pertinent regulations.

Financial Risks

We are in an active financing round, so we do need to attract financing, and this is probably the greatest risk for the company.

Supply Chain Risks

There are no supply chain issues for our company.

Natural Disasters and Epidemics

Natural disasters would impact us as much as any other company.

Dilution Risk

We will negotiate hard so as not to allow too much dilution in the company, and we are also looking for partners whose investment will not cripple the company in the future.

Need for Future Financing

We need 2000000 USD.

 
;